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Background: Normal, healthy human breast tissue from a variety of volunteer donors has become available for
research thanks to the establishment of the Susan G. Komen for the Cure® Tissue Bank at the IU Simon Cancer
Center (KTB). Multiple epithelial (K-HME) and stromal cells (K-HMS) were established from the donated tissue.
Explant culture was utilized to isolate the cells from pieces of breast tissue. Selective media and trypsinization were
employed to select either epithelial cells or stromal cells. The primary, non-transformed epithelial cells, the focus of
this study, were characterized by immunohistochemistry, flow cytometry, and in vitro cell culture.
Results: All of the primary, non-transformed epithelial cells tested have the ability to differentiate in vitro into a
variety of cell types when plated in or on biologic matrices. Cells identified include stratified squamous epithelial,
osteoclasts, chondrocytes, adipocytes, neural progenitors/neurons, immature muscle and melanocytes. The cells also
express markers of embryonic stem cells.
Conclusions: The cell culture conditions employed select an epithelial cell that is pluri/multipotent. The plasticity of
the epithelial cells developed mimics that seen in metaplastic carcinoma of the breast (MCB), a subtype of triple
negative breast cancer; and may provide clues to the origin of this particularly aggressive type of breast cancer.
The KTB is a unique biorepository, and the normal breast epithelial cells isolated from donated tissue have
significant potential as new research tools.
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Metaplasia is the appearance of a tissue type foreign to
the organ it arises in and results from a reprogramming
of stem cells that reside in normal tissues [1]. In the hu-
man breast, it is observed in both benign and malignant
lesions. The malignant version, metaplastic carcinoma of
the breast (MCB), encompasses squamous carcinoma,
squamous carcinoma with spindle cell metaplasia, car-
cinoma with chondroid differentiation, carcinoma with
osseous differentiation, and adenocarcinoma with spin-
dle cell differentiation [2]. Not infrequently, the metapla-
sia is not limited to one cell type (Figure 1). Gwin et al.
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reproduction in any medium, provided the orchondroid differentiation; fully a third also exhibited
squamous metaplasia [3]. An interesting observation is
that cartilage and bone formation are relatively frequent
occurrences in the mammary tumors of cats and dogs
[4]. Canine tumors containing epithelial and mesenchy-
mal components are hypothesized to arise from stem
cells based on the fact that the two components are
monoclonal [5,6]. Bone and cartilage are also observed
in pleomorphic adenoma of the salivary glands and
rarely in Calcifying Epithelioma of Malherbe [2]. Meta-
plasia also arises in the context of chronic inflammation;
for example, H. pylori infection of the gastric mucosa in-
duces intestinal metaplasia. This conversion is hypothe-
sized to be the result of a change in the expression of one
or several transcription factors in the adult stem cell [7].
The Susan G. Komen for the Cure® Tissue Bank at the
IU Simon Cancer Center is a biorepository establishedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Hematoxylin and eosin stained section of a metaplastic carcinoma of the breast. Asterisk indicates chondrocytic differentiation,
arrows mark squamous differentiation and star is in the middle of spindle cell differentiation. A. Low-magnification view, 4x. B. Higher magnification of
the section showing all three cell types.
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tissue from volunteer donors [8,9]. To increase the avail-
ability of a prohibitively limited resource, epithelial (K-
HME) and stromal cells (K-HMS) were established from
the donated tissue. The primary, non-transformed epithe-
lial cells, the focus of this study, were characterized by im-
munohistochemistry, flow cytometry, and in vitro cell
culture. During this process it has become apparent that
all of the epithelial cells tested have the ability to differen-
tiate in vitro into a variety of cell types when plated in oron biologic matrices. Classic germ layer theory posits that
some of these cell types have their origin in the ectoderm
but others are derived from the mesoderm or neural crest.
However, here is a growing body of evidence to suggest
that explant culture conditions, such as were utilized to
isolate these cells, select cells that are multipotent [10-14].
The plasticity of the epithelial cells developed by KTB
mimics that seen in MCB and it is tempting to postulate
that these tumors arise from similar multipotent or plastic
cells as described in the present study.
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All studies were approved by the Indiana University
Institutional Review Board (IRB-04; protocol number
0709–17; and NS1006-04). All research was carried out
in compliance with the Helsinki Declaration.
Experimental design
The original purpose of this study was the characterization
of the epithelial cells derived from the donated normal
breast tissue. Initial studies included immunohistochemis-
try to determine the expression of epithelial cytokeratins,
myoepithelial markers and hormone receptors; and ploidy
analysis. The first evidence of plasticity was observed in
the Matrigel® cultures. This observation shifted the focus
of this study to an assay of the epithelial plasticity. As
Matrigel® is a mixture of collagen, laminin and fibronectin,
cells were grown on each of these surfaces to determine if
any one of these proteins was responsible for the trans-
formed phenotype. Preliminary cell type identifications
were made based upon shape, size and intracellular com-
ponents on phase contrast microscopy. Colorimetric as-
says and immunohistochemistry were utilized to provide
additional evidence as to the cells’ identities. Alcian blue is
routinely used in pathology laboratories to identify cartil-
age and nestin expression is a marker of neural stem cells.
However, as both have been noted in normal breast epi-
thelium [15,16], additional makers of chondrocytic and
neural differentiation that are specific to the cell type were
assayed.
Cell culture
After obtaining informed consent, a 10 gauge core nee-
dle was used to obtain breast tissue (<100 mg) from 39
healthy female volunteers with no history of breast dis-
ease (see Additional file 1: Table S1 for age, race, and
Gail risk score) [8]. The tissue was immediately homoge-
nized, digested with collagenase and hyaluronidase, and
cultured using selective media and trypsinization to dif-
ferentiate the epithelial cells from stromal cells as previ-
ously described [17-21]. The KTB HME cells (K-HME;
K-HME 490, K-HME 509, K-HME 538, K-HME 496, and
K-HME 511) were obtained from frozen stocks, thawed,
and suspended in WIT-P media (Stemgen, San Diego,
CA, USA) unless otherwise stated (see Additional file 2:
Methods) then plated onto Primaria-coated T-25 flasks
(BD Bioscience, San Jose, CA, USA). The majority of ex-
periments used cells prior to passage four; no follow-up
experiments utilized cells beyond passage 14. Cells were
cultured at 37°C, in an environment of 95% relative hu-
midity and 5% CO2.
Ploidy status
Fluorescence in situ hybridization (FISH) with centromere
probes from chromosome X (CEPX) and chromosome 17(CEP17) were performed as described by Grimes and col-
leagues [22].
3-D Matrigel® culture
125,000 K-HME cells were grown in the middle of a
Matrigel® (BD Bioscience, San Jose, CA, USA) sandwich
culture in a 24-well plate. After approximately 10 days,
the cultures were encapsulated in HistoGel™ (Richard-
Allen Scientific, Kalamazoo, MI, USA), formalin-fixed
and paraffin-embedded. Immunohistochemistry (IHC)
was performed by the IUH Pathology Laboratory using
the Dako AutostainerPlus (Dako, Carpinteria, CA, USA)
and the protocols given in Additional file 1: Table S2.
The primary antibody was eliminated to prepare the
negative controls of all immunohistochemistry reactions.
Differentiation analyses of cultures grown on coated
surfaces
Chondrocytic differentiation
6-well plates coated with Type IV Collagen, Laminin, Fi-
bronectin, and Primaria™ surface treatment were ob-
tained from BD Biosciences (San Jose, CA, USA). 6.5 ×
105 K-HME cells were pipetted onto each of the coated
surfaces of the culture plates. Cells were incubated for
10–12 days with a change of media every other day. The
Alcian blue pH 2.5 Stain Kit (Artisan™, Dako, Carpinteria,
CA, USA) was used per manufacturer’s instructions.
Two wells of a 4-well culture slide (Lab-Tek, Scotts
Valley, CA, USA, #154526) were coated with collagen
(Stem Cell Technologies, Vancouver, BC, Canada; #04902)
and 2.5 × 104 cells were plated per well. The cells were
grown on the surface of the slide or on the collagen in
WIT-P media for 6 days. Cells were fixed in 10% buffered
formalin. Anti-Collagen II and X IHC was carried out as
given in Additional file 1: Table S2.
Osteocytic differentiation
Cell culture plates, cell number and incubation duration
are as given for chondrocytic differentiation. The TRACP
& ALP double-stain kit (Takara, Shiga, Japan) was used
per manufacturer’s instructions.
Adipocytic differentiation
Cell culture plates, cell number and incubation duration
are as given for chondrocytic differentiation. Cells were
fixed in paraformaldehyde (4% paraformaldehyde, 0.15%
picric acid in PBS) for 1 hour at RT and then incubated
with Oil Red O (Sigma-Aldrich, St. Louis, MO, USA) for
1 hour at 37°C.
Neural differentiation
Human Type IV Collagen was obtained from BD Biosci-
ences (San Jose, CA, USA) and diluted 1:5 in 10 mM
acetic acid). 125 μl of the collagen solution was used to
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(BD Falcon, Franklin Lakes, NJ, USA; cat. no. 354118).
Human nestin monoclonal antibody (Clone 196908,
MAB 1259), neuron-specific beta-III tubulin monoclonal
antibody (Clone TuJ-1, MAB 1195), and Northern-
Lights™ 557-conjugated sheep polyclonal anti-human
GFAP (NL2594R) were obtained from R&D Systems,
Minneapolis, MN, USA. Human nestin and neuron-
specific beta-III tubulin antibody solutions were diluted
1:100 in blocking buffer (BB) and incubated with the
cells overnight at 4°C. Anti-human GFAP was diluted
1:10 in BB and incubated with the cells for 3 hours in
the dark at RT. Cells and primary antibody were incu-
bated with secondary antibody (1:200 in BB; Northern
Lights™ fluorescent secondary antibody NL-557 anti-
Mouse IgG (NL007); R&D Systems, Minneapolis, MN,
USA) for 1 hour in the dark at RT. They then were incu-
bated for 5 minutes with 300 nM DAPI (Molecular
Probes, Grand Island, NY, USA) in the dark. They were
stored at 4°C until microscopy.
Two wells of a 4-well culture slide (Lab-Tek, Scotts
Valley, CA, USA, #154526) were coated with collagen
(Stem Cell Technologies, Vancouver, BC, Canada; #04902)
and 2.5 × 104 cells were plated per well. The cells were
grown on the surface of the slide or on the collagen in
WIT-P media for 6 days. Cells were fixed in 10% buff-
ered formalin. Neu-N IHC was carried out as given in
Additional file 1: Table S2.
Melanocytic differentiation
Two wells of a 4-well culture slide (BD Falcon, Franklin
Lakes, NJ, USA; #354104) were coated with collagen
(Stem Cell Technologies, Vancouver, BC, Canada; #04902)
and 3 × 104 cells were plated per well. The cells were
grown on the surface of the slide or on the collagen, and
in either Melanocyte Growth Medium (ZenBio, Inc.,
Durham, NC, USA) or WIT-P. After 3 days, the cells
were fixed in 4% paraformaldehyde. Anti-MART-1 IHC
was carried out as given in Additional file 1: Table S2.
Organotypic culture
Normal human dermal fibroblasts and Type 1 Collagen
(Becton Dickinson, Franklin Lakes, NJ, USA) were mixed,
polymerized and cultured as previously described [23]
with modifications. After allowing 2 days for the fibro-
blasts to contract and reorganize the tissue, K-HME cells
were plated on the upper surface at a concentration to
provide a confluent monolayer of cells (200,000 cells per
cm2). Culture continued for 2 days submerged in kera-
tinocyte medium [24] with 20 μg/ml ascorbic acid (Sigma-
Aldrich, St. Louis, MO, USA). For air/liquid interface
culture, tissues were transferred to clear Transwell 6-
well inserts (Corning Costar, Tewksbury, MA, USA) and
placed into deep-well dishes (BioCoat, Becton Dickinson,Franklin Lakes, NJ, USA) for the remainder of the culture
period. 16 hours prior to harvest, cultures were treated
with 10 μM 5-ethynyl-2′-deoxyuridine (EdU; Invitrogen,
Carlsbad, CA, USA) to label proliferating cells. Samples
were harvested at 1, 3, and 7 days then prepared for frozen
sections.
Immunohistochemistry
5 × 105 cells in WIT-P media were plated per well of a
chamber slide (BD Falcon, San Jose, CA, USA) and the
cells incubated overnight. Cells were fixed using 4%
paraformadehyde, 0.15% picric acid in 1 × PBS for
20 minutes at RT. OCT4, NANOG and MyoD immu-
nohistochemistry were performed per the protocols
given in Additional file 1: Table S2. EGFR IHC was per-
formed using the EGFR (Dako) RTU primary antibody
and the EGFR pharmDX Kit (Dako), which was used
according to the manufacturer’s instructions.
Immunofluorescence
Cells grown on chamber slides (BD Falcon, Franklin
Lakes, NJ, USA) were fixed with 4% paraformaldehyde
(10 min.) and permeabilized with 0.1% Triton X-100
(10 min.) before blocking with 3% BSA in 1 × PBS
(1 hr). Primary antibodies (CK 5/6, CK 8/18, CK 14, CK
19, EMA, SMA, Thermo Fisher Scientific, Kalamazoo,
MI, USA; p63, Sigma-Aldrich, St. Louis, MO, USA;
vimentin, Cell Signaling, Danvers, MA, USA) were di-
luted 1:100 in 1% BSA in 1 × PBS and incubated with
the cells for 2 hrs. Binding of a 1:600 dilution of appro-
priate Alexa-Fluor 468 anti-mouse IgG or Alexa-Fluor
588 anti-rabbit IgG secondary antibodies (Molecular
Probes, Eugene, OR, USA) in 1% BSA in 1 × PBS oc-
curred during 1 hr. The slides were mounted with Vecta-
shield containing DAPI (Vector Laboratories, Burlingame,
CA, USA) and cells were examined using a Leica fluores-
cent microscope (where exposure time and gain settings
were set according to the background levels of the second-
ary antibody only sample).
Cells were incubated overnight at 4°C with anti-
human Nucleostemin (R&D Systems, Minneapolis, MN,
USA; AF1638, 10 μg/ml). Cells and primary antibody
were incubated with a 1:200 dilution of Northern Lights™
anti-goat IgG (NL493) for 1 hour in the dark. Cells were
washed and incubated with DAPI as above. Confocal mi-
croscopy was performed using an Olympus FV1000-MPE
Confocal/Multiphoton Microscope; absorption 493 nm,
emission 514 nm.
For organotypic cultures, frozen sections were perme-
abilized with 80% MeOH for 5 min. at 4°C and acetone
for 2 min. at −20°C prior to staining. Nonspecific stain-
ing was blocked by 10% goat serum. Sections were incu-
bated for one hour in a PBS solution containing one of
the following primary antibodies: Keratin-10 (1:200, clone
Figure 2 Verification of epithelial lineage. Immunohistochemistry
using the AE1/AE3 antibody mixture in representative K-HME cells.
AE1 recognizes acidic (type 1) cytokeratins (K10, 15, 16 and 19) and
AE3 all known basic (type II) cytokeratins.
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Cadherin (1:400, clone EP700Y; Epitomics, Burlingame,
CA, USA), Involucrin (1:200, clone SY5; Sigma-Aldrich,
St. Louis, MO, USA), Keratin-14 (1:200; Thermo Scien-
tific, Waltham, MA, USA), or p63 (1:100, clone EPP5701;
Abcam, Cambridge, MA, USA). Primary antibodies were
visualized by staining one hour with goat anti-mouse
rhodamine red or goat anti-rabbit Alexa 488 (Molecular
Probes, Invitrogen, Carlsbad, CA, USA). Nuclei were
counterstained with 30-minute incubation with Hoechst
stain (1:2000; Invitrogen Carlsbad, CA, USA). Double-
staining for keratin-14 and involucrin was described
previously [23]. EdU was visualized using a kit as per
manufacturer’s instructions (Click-It, C10337; Invitro-
gen). Stained slides were viewed and photographed
using an IX-71 inverted fluorescence microscope with
DP71 camera and cellSens software (Olympus Imaging
America Inc, Center Valley, PA, USA).
The negative controls of all immunofluorescence were
isotype antibodies used at the identical concentration.
Clonality
100 μL of K-HME 496 cell suspension (10 cells/ml WIT-
P) was added to each well of two Primaria 96 well plates
and two collagen-coated 96 well plates (BD Biosciences,
San Jose, CA, USA). Cells were observed at day 1 of cul-
ture to identify wells with one cell only present and then
subsequently observed for the growth of colonies from
the single cell.
Telomerase activity by the Telomeric Repeat
Amplification Protocol (TRAP)
Telomerase activity was measured using the TRAP-eze
Telomerase Detection kit (Billerica, MA, USA) and
established protocols [25,26].
Flow cytometry
Flow cytometry was carried out using a FACSCalibur
flow cytometer (BD Biosciences, San Jose, CA, USA)
and the CellQuest program to capture at least 10,000
events.
Quantitative PCR
Human embryonic stem cell total RNA was obtained
from Celprogen (San Pedro, CA, USA). Total RNA was
isolated from the K-HME cells using the miRNeasy®
Mini Kit (Qiagen, Valencia, CA, USA). PCR amplification
was carried out using a BioRad CFX96 Real-Time System
C1000 (BioRad, Hercules, CA, USA). cDNA was synthe-
sized using the Tetro cDNA Synthesis Kit (Bioline,
Tauton, MA, USA). 100 ng of cDNA mixed with 5 μL
2× SensiMix SYBR N0-Rox Kit (Bioline) and 200 nM of
each primer (Sigma, St. Louis, MO, USA; Applied Bio-
systems, Carlsbad, CA, USA: OCT4 (POU5F1) primer/probe set, Hs04260367_gH, cat# 4351372, NANOG pri-
mer/probe set Hs04260366_g1, cat# 4351372; and GAPDH
primer/probe set, Hs99999905_m1, cat# 4331182) in a
final volume of 10 μL.
Results
K-HME cells express common epithelial and myoepithelial
markers by immunohistochemistry
The K-HME cells are epithelial in nature (AE1/AE3
positive; Figure 2) and do not express estrogen receptor
(ER), progesterone receptor (PR) or HER2 protein (Table 1).
Cytokeratin 5/6 expression was observed in cells cultured
in both MEGM and WIT-P media; cytokeratin 8/18 expres-
sion was seen only when grown in WIT-P. The expression
of other proteins varied as a function of the growth media;
for example vimentin expression was observed in WIT-P
media but not in MEGM (Table 1). The epithelial cells
expressed p63, a protein essential for the self-renewal of
stem cells of epithelia [27], and a marker of myoepithelial
cells [28]; and alpha smooth muscle actin, which is associ-
ated with both myoepithelial cells and myofibroblasts.
The majority of K-HME cells are diploid
The majority of the established breast epithelial cells are
diploid (96.9%; 190/196 cells) as evidenced by two chromo-
some 17 and two chromosome X signals. A small percent-
age of cells (3.1%) were tetraploid at passage 3 and
exhibited four X signals and four chromosome 17 sig-
nals each (Figure 3).
Cell phenotype of the K-HME cells in the presence of
basement membrane proteins
When the cells were placed in the center of a sandwich
of Matrigel®, they uniformly formed spheres 37 mm-
325 mm in diameter after 10 days in culture (Figure 4A).
Table 1 Characterization of the cells by protein
expression. Immunohistochemistry and
immunofluorescence were performed, and expression of
various markers evaluated as a function of growth
surface and media
Media: MEGM; Media: Wit-P
Surface: Plastic Surface: Primaria
Marker Cells Marker Cells
ER - ER -
PR - PR -
HER2 - HER2 -
CK 5/6 + CK 5/6 +
p63 + p63 +
SMA +/− SMA +
vimentin - vimentin +
CK 19 - CK 19 -
EGFR - CK 14 +
CK 8/18 +
AE 1/3 +
Figure 3 Ploidy status in K-HME cells. A. Metaphase chromosome
spread hybridized with X (red; arrowheads) and 17 (green; arrows)
centromere probes. B. Interphase cells hybridized with X (red) and
17 (green) centromere probes. The majority (96.9%) of the established
breast epithelial cells are diploid (190/196 cells) as evidenced by
two chromosome 17 and two X chromosome signals. A small
percentage of cells (3.1%) were tetraploid at passage 3 and exhibited
four X chromosome and four chromosome 17 signals.
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and paraffin-embedded sections of these spheres reveals
a keratinizing squamous epithelium (Figure 4B). The
cells initially appeared to be forming duct-like struc-
tures, which disappeared over the 10 days of culture
(Figure 4C).
Immunohistochemistry was repeated on sections
showing squamous differentiation. In comparison to
cells in 2-D culture, these cells strongly expressed the
epidermal growth factor receptor and vimentin; did not
express SMA (Additional file 3: Figure S1A,C,E) and
contained a few, scattered CD10 positive cells (Add-
itional file 3: Figure S1D). Single cells appeared CK18
positive; however, those cells within the spheres were
very weakly CK 18 positive; ER, PR, HER2 remained
negative.
Three of the twelve K-HME cell strains (K-HME 538,
K-HME 496, and K-HME 511) were chosen for add-
itional characterization. Photomicrographs of the breast
tissue from two of these three donors are presented in
Additional file 3: Figure S2A,B. These cells were grown
on Collagen I, Collagen IV, Laminin, Fibronectin and
Primaria surfaces. The most striking differentiation was
observed on the Collagen IV and Fibronectin surfaces,
although this was observed on Primaria dishes as well.
Multiple cell types were observed including large, multi-
nucleated cells, which resembled osteoclasts both by
morphology and upon Tartrate Resistant Acid Phosphat-
ase staining (Figure 5Ai, ii). Incubation of the cell cul-
tures with Alcian blue highlighted the presence of
glycosaminoglycans in another subfraction of the cells
(Figure 5Bi, ii). Immunohistochemistry using antibodiesdirected against collagen II and X revealed granular
cytoplasmic staining in a fraction of cells when grown
on collagen or Primaria (Figure 5Biii and iv, respect-
ively). The phenotype of the cells, the positive staining
with Alcian blue, and the production of collagen II and
X suggest chondrocytic differentiation [29,30].
Spindle-shape cells with Oil Red O positive cytoplas-
mic vacuoles consistent with adipocytes were observed
(Figure 5Ci, ii). In other areas of the cell culture, a sheet
of MyoD expressing cells was seen (Figure 5Di, ii).
Figure 4 Squamous differentiation. K-HME cells were grown in the center of a Matrigel® sandwich. A. Phase contrast; and B. Hematoxylin and
eosin stained section after 10 days. Bright-pink center is keratin (*), the triangle indicates an area equivalent to the stratum corneum, the arrows
identify cells equivalent to the stratum basale of a stratified epithelium. C. Phase contrast of similar culture after 1 day 20×
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nestin, glial fibrillary acidic protein (GFAP), and beta-III
tubulin (Figure 5Ei). Immunohistochemistry using anti-
bodies directed at the neuron-specific nuclear protein
NeuN (or Neuronal Nuclei) [31] showed uniform nu-
clear staining (Figure 5Eii) in a fraction of cells when
grown on collagen but not on Primaria. A subpopula-
tion of cells expressed the melanocyte differentiation
antigen MART-1 (Figure 5F). The addition of BMP4 or
neuregulin to the culture media did not enhance osse-
ous or neural differentiation, respectively. Growth of the
cells in Melanocyte Growth Medium did not promote
the expression of MART-1.Clonality
Analysis of a single cell suspension of K-HME 496 cells
revealed that the various cell types are represented in a
colony that grew from a single cell (Additional file 3:
Figure S3). Each cell type represented only a fraction of
the total cells (Additional file 3: Figure S4A). Flow cyto-
metric analysis determined that 25% of cells expressed
CD151 (chondrocyte) [32,33] and 5% expressed the Cal-
citonin R (osteoclast) [34] (Additional file 3: Figure S4B).Organotypic culture
In organotypic culture, K-HME cells partially differenti-
ated into a stratified epithelium that showed E-cadherin
rich junctions characteristic of skin (Figure 6A-D). Kera-
tin 10, a suprabasal keratin of the epidermis, was also
noted (Figure 6E). Similarly, expression of involucrin
(Figure 6F), a crosslinking protein found in upper strata
of epidermis and Keratin-14 (Figure 6F), a basal-layer
keratin of epidermis, were observed in the top and bot-
tom layers, respectively. p63, which is expressed in the
basal layer of epidermis, also was present in the K-HME
cells at the bottom of the tissue (Figure 6G). There was
no change in staining after 1, 3 and 7 days of emersion.
Cell division occurred in cells near the basal layer with
approximately 10% of the basal cells undergoing cell div-
ision (Figure 6H-K).
Expression of breast stem cell markers in K-HME cells
Flow cytometry for stem cells markers showed the cells
were CD49f positive and EpCAM negative (Figure 7). K-
HME cells grown in WIT-P media were positive for
telomerase activity, an indicator of progenitor cell char-
acteristics, while those grown in MEGM were negative
unless transduced with exogenous hTERT. (Additional
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Figure 5 Differentiation of K-HME cells. Osteoclast: A.i. Phase contrast, Laminin, 20x, A.ii. Tartrate resistant acid phosphatase (TRAP). The bright
pink is indicative of TRAP activity. Chondrocyte: B.i. Phase contrast, 40x, ii. Alcian blue staining. The blue color is due to the glycosaminoglycans
synthesized by chondrocytes. iii. IHC anti-collagen II, iv. IHC anti-collagen X. Adipocyte: C.i. Phase contrast, ii. Oil Red O staining. Muscle: D.i. Phase
contrast, Collagen IV, 20x; ii. MyoD immunohistochemistry. MyoD is an immature muscle marker. Neural: E.i. immunofluorescence β-III tubulin,
glial fibrillary acid protein (GFAP) and nestin. β-III tubulin is expressed by differentiated neurons. GFAP is expressed by mature astrocytes and
distinguishes astrocytes from other glial cells during development. Nestin expression marks stem cells of the central nervous system. ii. IHC
anti-NeuN. Melanocyte: F. Immunohistochemistry using anti-MART-1 (anti-Melan-A; melanocyte differentiation antigen), 20x. Positive and negative
controls stained appropriately, A-F.
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Figure 6 Organotypic cultures. K-HME cells form a stratified epithelium in organotypic cultures. A.B. Culture after 1 day, emerged; C. culture
after 7 days, emerged. D. E-cadherin staining. E. Keratin 10, a suprabasal keratin of the epidermis. F. Involucrin (red) found in the upper strata of
the epidermis and Keratin 14 (green) a basal-layer keratin. G. p63 found in the basal layer of the epidermis. H-K. Cultures were treated with
ethynyl deoxyuridine (EdU) followed by a ‘click’ reaction to visualize cells that had entered S phase (green). H. Day 1 emerged; I. Day 3 emerged;
J. Day 7 emerged; K. Day 3 emerged, magnified.
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HME cells express the stem makers KLF4, NANOG,
NOTCH1 and SOX2 at levels similar to embryonic stem
cells (Additional file 3: Figure S6). Data is normalized to
GAPDH. Expression of embryonic stem cell markers
NANOG and OCT4 was verified at the protein level and
was observed in a fraction of the cells by immunohisto-
chemistry (Figure 8A, B). OCT4 RNA expression was
lower by qPCR, which is consistent with the IHC as not
all cells expressed the protein. Immunofluorescence using
antibodies against nucleostemin confirmed the presence
of multiple nucleoli in a subset of cells (Figure 8C).
Discussion
Identification of the mammary epithelial stem cell has
been a “source of much contention” [35]. Methodologies
utilized for the identification include mammosphere cul-
ture, fluorescence-activated cell sorting, and recapitula-
tion of the mammary gland by single cells in vivo. “Since
metaplasia often involves the transformation of undiffer-
entiated stem or progenitor cells…” [36], metaplastic
ability may be another attribute of these cells.
While no single marker can be considered to be cell-
type specific, the preponderance of evidence presentedin this paper including cellular phenotype, colorimetric
reactions and multiple immunostains suggest that the K-
HME cells are multipotent. Explant culture conditions
select cells that are multipotent. Multipotency has been
demonstrated for explant cultures of the hair follicle,
bronchiole and intestine [10-14]. Sieber-Blum and col-
leagues showed that cells from bulge explants of whis-
kers of transgenic mice are pluripotent, differentiating
into neurons, smooth muscle, Schwann cell, melano-
cytes, and chondrocytes [10]. Using Wnt10cre/R26R
double transgenic mice, they were able to trace these
cells to the neural crest. A subsequent study by Yu et al.
confirmed differentiation into neurons, muscle cells,
endothelial cell, adipocytes and osteoblasts [11]. The cell
line developed by Delgado and colleagues from bronchi-
ole explants co-express differentiation markers for mul-
tiple cell types of the lung and give rise to all lung
epithelial lineages [12]. Intestinal explant cultures or
“organoids” are multi-cellular aggregates of intestinal
mucosal progenitors and putative mucosal stem cells,
which have been seeded onto scaffolds in tissue engin-
eering experiments to create neointestines [13,14]. The
cells most competent to emerge from tissue explant cul-
tures would appear to be the basal cells, which display
Figure 7 Flow cytometry. Representative FACS dotplots of K-HME cells labeled with CD49f and EpCAM antibodies. The CD49fhiEpCAM− subset
has been associated with the mammary stem cell enriched subpopulation [47]. A. K-HME 496; B. K-HME 511.
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Figure 8 Embryonic stem cell markers. Immunohistochemistry: A. NANOG; B. OCT4. The majority of nuclei in the NANOG IHC are brown
indicating the presence of NANOG. Some, but not all, nuclei are positive for OCT4. Negative (secondary antibody only) and positive (seminoma)
controls are presented in the thumbnails below the photomicrographs. C. Immunofluorescence against nucleostemin. Left: anti-nucleostemin
antibody, center: DAPI, right: merge. Bar = 10 microns.
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cells described herein established by outgrowth from ex-
plant culture are basal and retain multipotency. Both
Delgado et al. and Yu et al. suggest that their isolated
cells resemble multipotent embryonic progenitors either
in terms multi-lineage differentiation and/or expression
of NANOG and OCT4. Human lung stem cells isolated
by Wang and colleagues express NANOG, OCT3/4,
SOX2 and KLF4 [37]. Indeed, expression of OCT4 and
NANOG has been reported in rare cells within adult tis-
sues including bone marrow, epidermis, bronchial epi-
thelium, myocardium, pancreas and testes [38]. Likewise
a subpopulation of K-HME cells express OCT4 and
NANOG. K-HME cells also display multiple nucleoli, a
characteristic of human embryonic stem cells [39].
A recent publication from the laboratory of Tlsty and
colleagues reports findings similar to the ones presented
in this manuscript [40]. The cells utilized for their stud-
ies were isolated by a completely different method, i.e.,
the selection by flow cytometry of cells from reduction
mammoplasties that, after lineage depletion, are CD73positive and CD90 negative. These cells are also pluripo-
tent and express a number of genes reported to confer
multi-and pluipotency at levels comparable to embry-
onic stem cells. Although there are a number of similar-
ities to the K-HMEs there are also some differences, e.g.,
their cells are EpCAM positive, and differentiation was
effected by the addition of growth factors and supple-
ments to the media. These differences notwithstanding,
the fact that two independent laboratories using differ-
ent methods have identified pluripotent, plastic cells in
the breast lends credence to this discovery.
The epithelial cells described herein are metaplastic.
They express basal cytokeratins 5 and 14, which are the
hallmarks of the basal cells of stratified squamous epi-
thelia [3], and myoepithelial cells/basal cells of the nor-
mal breast. However, a subset of luminal cells in the
terminal ducts also express cytokeratin 5 [35]. In the
mouse mammary gland, the basal cell fraction is
enriched in mammary stem cells [41]. The expression of
the luminal cytokeratins 8 and 18, and of vimentin in
WIT-P media is of interest. WIT-P media in contrast to
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has been shown to significantly increase the expression
of cytokeratins 8, 18, 19, vimentin and ICAM-1 in oral
gingival cells in vitro [42]. It also increases expression of
these cytokeratins in T47D breast cancer cells [43]. Ince,
Weinberg and colleagues, selected primary breast epi-
thelial cells by their growth in WIT-P media and trans-
fected them with hTERT, SV-40 LT/st and H-ras-v12.
The xenograft tumors formed from these cells expressed
cytokeratins 8 and 18 and resembled human invasive
ductal carcinoma [44]. Those cells selected by their
growth in MEGM resulted in tumors with squamous dif-
ferentiation that lacked CK8/18 expression. p63, which
is routinely used as a marker of myoepithelial cells, is
strongly expressed by the K-HME cells. However, it is
also a stem cell marker in the epidermis and limbal epi-
thelium [45]. In p63-null mice, the epithelium fails to
stratify, and mammary buds or other epidermal append-
ages do not form [46]. Pellegrini and colleagues have ar-
gued that the phenotype of p63-null mice should be
ascribed to a failure to maintain the stem cell compart-
ment. This would suggest that p63 marks the stem cells
of the epidermal appendages, which includes the mam-
mary glands, as well as the epidermis and limbic epithe-
lium. It is entirely possible that the K-HME cells are the
p63, CK14 and nestin positive cells identified by Li et al.
in the basal/myoepithelial layer of the mammary gland
[15]. K-HME cells are EpCAM negative and CD49f posi-
tive by FACS analysis, an immunophenotype ascribed by
Lim et al. to the mammary stem cell enriched population
[47].
The differentiation of human breast cells obtained
from outgrowth of organoids into squames is well de-
scribed [48]. The ability of these basal cells to form
“relatively large spherical structures with a central core
of squamous metaplasia” on basement membrane has
also been noted [49,50]. Squamous differentiation of
cells isolated from reduction mammoplasty has more re-
cently been reported [51,52]. Both nasal airway stem
cells and tracheal airway stem cells form spheres of
squamous cells “akin to squamous cell metaplasia” when
grown on Matrigel® [53]. It should be noted that the
squamous differentiation observed in our study is con-
textual: In the middle of Matrigel®, the phenotype most
closely represents a squamous carcinoma of the skin.
This keratin pearl-like structure is the form assumed by
squamous metaplasia in the breast both in benign (e.g.
adenomyoepitheliomas) or malignant (e.g., metaplastic
squamous cell carcinoma) lesions. It is also observed in
squamous cell carcinoma of the lung, esophagus, anus
and even in a minority of tibial adamantinomas [54].
This suggests a commonality in the pathophysiology of
the metaplasia, that is, that basal/stem cells on becoming
surrounded on all sides by basement membrane/stromaform keratin pearl structures. The fact that this is ob-
served in normal cells raises the possibility that metapla-
sia is a property of all epithelia, which is kept in check
by the normal microenvironment and tissue polarity. In
a study conducted by Miyoshi and colleagues using
transgenic mice, stabilization of β-catenin expression
through MMTV-Cre-induced deletion of exon 3 results
in reversion to epidermis and squamous metaplasia in
the mammary tumors that develop therein [55]. This
squamous metaplasia resembles that seen in the Matri-
gel® sandwich cultures in that there is a cyst-like/nodular
structure with keratin in the middle encircled by a strati-
fied epithelium. These investigators suggest that the dif-
ferentiation of the mammary gland as a secretory
epithelium requires suppression of β-catenin signaling,
and absent this repression the phenotype reverts to epi-
dermis [55]. In other words, the default genetic program
for epithelial cells in the breast may be epidermis and
their differentiation into a gland requires, at a minimum,
the repression of the default program, if not a concomitant
activation of a program that results in gland formation.
How can differentiation into these various cell types
be explained? Boecker and colleagues recently published
a study of salivary gland tumors of the breast and histo-
logically similar tumors of the salivary and lacrimal
glands [56]. They utilized triple immunofluorescence to
trace the lineage of cells within these tumors. The re-
sults of their study led them to hypothesize that there
are K5/K14/p63-positive progenitor cells within these
neoplasms that give rise to glandular epithelial cells,
myoepithelial cells, as well as the squamous and mesen-
chymal cells. The K-HME cells may be the progenitor
cells hypothesized by Boecker et al.
Eric Neilson has suggested that terminal differentiation
rather than being an end point is a lay-over point: “…ter-
minal differentiation is really just an evolutionary pause
maintained by signaling events, transcription factors,
and genomic setting” [57]. Neilson and his colleague,
Michael Zeisberg, have proposed that epithelial plasticity
is comprised of two processes: Metaplasia (transdifferen-
tiation) and epithelial-mesenchymal transition (EMT)
[57,58]. EMT can further be divided into three types
[58,59]. Type 1 EMT functions in early embryogenesis
when it is involved in gastrulation and neural crest mi-
gration. Type 2 EMT is the formation of fibroblasts from
secondary epithelial cells or endothelial cells. Type 3
EMT facilitates the metastasis of epithelial cells in a
process that includes the loss of intercellular connec-
tions, migration and the establishment of residence in a
secondary location.
Metaplasia is often composed of the tissue type nor-
mally derived from the neighboring region of the em-
bryo [36,60]. A dividing line forms between these two
regions at a point where an inducer is at its threshold
Sauder et al. BMC Cell Biology 2014, 15:20 Page 13 of 15
http://www.biomedcentral.com/1471-2121/15/20concentration [61]. If a stem cell originally residing in
this region and now in one of the resulting adult tissues
retains bidirectional tissue potential, an inciting event
after birth, e.g., infection, wounding, tissue regeneration,
could tip the balance resulting in an homeotic trans-
formation. The cells that eventually form the breast
begin their life as ectoderm, which borders the neural
crest. Neural crest cells form cartilage, bone, nerve and
smooth muscle in face and cranium; as well as the per-
ipheral nervous system and a number of neuroendocrine
cell types. Pleomorphic adenomas, tumors that also dis-
play areas of bone and cartilage formation, are hypothe-
sized to have a contribution from neural crest cells
based upon the expression of GFAP [62]. Human genetic
disorders may provide an additional clue. Mutation of
p63 is responsible for Limb-mammary syndrome
(OMIM #603543), the features of which include hypo-
plasia/aplasia of the mammary gland and cleft palate.
That the phenotype is manifest in tissues derived from
the ectoderm and neural crest suggests that the muta-
tion was present in a progenitor of both lineages. Are
the K-HMEs just such a cell? If so, the observed pheno-
typic plasticity observed in the K-HME cells may be
more akin to Type 1 rather than Type 3 EMT.Conclusions
Within the normal human breast are epithelial cells with
phenotypic plasticity. They are likely the source of meta-
plasia. Metaplasia may offer a wealth of clues with re-
gard to normal and pathologic physiology. The human
body has regulated differentiation so that specialized tis-
sues and cells are generated and located/arranged to en-
able the organism to survive, thrive and function. When
this differentiation goes awry, it should prompt the ques-
tion: Why? What is a chondrocyte doing in the breast?
Many tissues have been shown to contain cells that are
pluri/multipotent. These cells function in the mainten-
ance of tissue homeostasis or the restoration of tissue in-
tegrity following wounding or remodeling. The plasticity
of the K-HME cells mimics that seen in MCB and it is
tempting to postulate that these tumors arise from simi-
lar multipotent or plastic cells. The differentiation reper-
toire of these cells may be circumscribed under normal
physiologic conditions by the tissue microenvironment.
Alteration of the microenvironment by a mechanical
and/or disease processes may release the restrictions en-
abling the metaplastic phenotype to become evident.Additional files
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